Glucagon Like Peptide-1 in Remote Ischemic Conditioning
NCT02746757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2018-03-07
Summary
The study was designed to investigate whether glucagon like peptide-1 is a mediator of protection of endothelial function induced by remote ischemic conditioning in ischemia-reperfusion
Conditions
- Healthy Volunteers
Interventions
- OTHER
-
Remote conditioning
- DRUG
-
Exendin 9-39
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2017-12-31
- Completion
- 2018-01-31
Countries
- Sweden
Study Locations
More Related Trials
-
Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines
NCT03241303 ·Status: COMPLETED ·Phase: NA
-
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.
NCT07224334 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
NCT00418288 ·Status: COMPLETED ·Phase: NA
-
Study on Lixisenatide and Counterregulation to Hypoglycemia
NCT02020629 ·Status: COMPLETED ·Phase: PHASE4
-
Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion
NCT04061473 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
NCT01825148 ·Status: COMPLETED
-
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
NCT03835013 ·Status: COMPLETED ·Phase: NA
-
Determinants of Diabetes Remission After Gastric Bypass Surgery
NCT02287285 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
NCT02001363 ·Status: UNKNOWN ·Phase: NA
-
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741 ·Status: COMPLETED
-
Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus
NCT00923962 ·Status: COMPLETED ·Phase: NA
-
Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
NCT05076292 ·Status: COMPLETED ·Phase: NA
-
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
NCT02847403 ·Status: UNKNOWN ·Phase: PHASE3
-
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
NCT03356457 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
NCT04733508 ·Status: UNKNOWN ·Phase: NA
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.
NCT03444467 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
NCT00256256 ·Status: COMPLETED ·Phase: NA
-
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
NCT01803451 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity
NCT01918566 ·Status: COMPLETED ·Phase: NA
-
The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans
NCT00273000 ·Status: UNKNOWN ·Phase: NA
-
Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus
NCT00655603 ·Status: UNKNOWN ·Phase: NA
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Glucagon-like Peptide-1 in Type 1 Diabetes
NCT04355832 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
NCT01843855 ·Status: COMPLETED ·Phase: EARLY_PHASE1